Dr. Janice J Brown, MD is a Infectious Disease Specialist - General, Hematology / Oncology Specialist - Hematologist (Blood) practicing in Stanford, CA
She has not yet shared a personalized biography w… Read more ›
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Virginia | Other Degree | 1987 |
| Institution | Focus | Year |
|---|---|---|
| Internship - Stanford University School of Medicine,Stanford, Ca, United States | 1988 | |
| Residency - Stanford University Medical Ctr | Not Specified | |
| Residency - Stanford University School of Medicine | 1990 | |
| Fellowship - Stanford University School of Medicine,Stanford, Ca, United States | 1993 |
| Position | Organization | Time |
|---|---|---|
| Professor of Medicine (Blood and Marrow Transplantation) | the Stanford University Medical Center | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | BONE MARROW TRANSPLANTATION | Long-term outcomes in patients with high | 2011 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Utility of Influenza Vaccition for Oncology Patients | 2010 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Safety and immunogenicity of a bivalent cytomegalovirus D vaccine in healthy adult subjects | 2008 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Protection against lethal Aspergillus fumigatus infection | 2005 |
| Other Publication | JOURL OF IMMUNOLOGY | Stepwise development of committed progenitors in the bone marrow | 2005 |
| Other Publication | BLOOD | Myeloid progenitors protect against invasive aspergillosis | 2002 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | Prophylactic administration of liposomal amphotericin B is superior to treatment | 2002 |
| Other Publication | JOURL OF GENERAL VIROLOGY | SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE | 1995 |
| Other Publication | JOURL OF INFECTIOUS DISEASES | DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE | 1995 |
| Other Publication | BONE MARROW TRANSPLANTATION | Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative | 2012 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative | 2011 |
| Other Publication | BONE MARROW TRANSPLANTATION | Long-term outcomes in patients with high | 2011 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High | 2011 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Combined Effects of Interleukin-7 | 2011 |
| Other Publication | ARTHRITIS CARE & RESEARCH | A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy | 2010 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Utility of Influenza Vaccination for Oncology Patients | 2010 |
| Other Publication | CLINICAL INFECTIOUS DISEASES | Comparison of polymerase chain reaction of polymorphonuclear leukocytes | 2008 |
| Other Publication | JOURNAL OF INFECTIOUS DISEASES | Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects | 2008 |
| Other Publication | BLOOD | The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation | 2008 |
| Other Publication | BLOOD | Cytomegalovirus MCK-2 controls mobilization | 2006 |
| Other Publication | JOURNAL OF INFECTIOUS DISEASES | Protection against lethal Aspergillus fumigatus infection | 2005 |
| Other Publication | JOURNAL OF IMMUNOLOGY | Stepwise development of committed progenitors | 2005 |
| Other Publication | BONE MARROW TRANSPLANTATION | Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic | 2005 |
| Other Publication | TRANSPLANT INFECTIOUS DISEASE | Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient | 2005 |
| Other Publication | CURRENT OPINION IN INFECTIOUS DISEASES | Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation | 2005 |
| Other Publication | CURRENT OPINION IN INFECTIOUS DISEASES | The influence of the conditions of hematopoietic cell transplantation on infectious complications | 2005 |
| Other Publication | BLOOD | Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following | 2005 |
| Other Publication | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease | 2005 |
| Other Publication | CURRENT OPINION IN INFECTIOUS DISEASES | Fungal infections in bone marrow transplant patients | 2004 |
| Other Publication | BLOOD | Common lymphoid progenitors rapidly engraft | 2003 |
| Other Publication | BLOOD | Myeloid progenitors protect against invasive aspergillosis | 2002 |
| Other Publication | JOURNAL OF INFECTIOUS DISEASES | Prophylactic administration of liposomal amphotericin B is superior to treatment | 2002 |
| Other Publication | CURRENT OPINION IN IMMUNOLOGY | Immunity to infections following hematopoietic cell transplantation | 2001 |
| Other Publication | VIROLOGY | Reassessing the organization of the UL42 | 1997 |
| Other Publication | JOURNAL OF GENERAL VIROLOGY | SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE | 1995 |
| Other Publication | JOURNAL OF INFECTIOUS DISEASES | DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE | 1995 |
Dr. Janice J Brown, MD has not yet indicated the hospitals that she is affiliated with.
Years In Practice: 30 (started in 1994)
Accepts New Patients: Yes
Dr. Janice J Brown, MD has not yet listed the medications that she commonly prescribes.
Dr. Janice J Brown, MD has not yet added any information about her practice's billing policies and payment options.
